Antibiotice S.A. (BVB:ATB)
Romania
· Delayed Price · Currency is RON 2.395
-0.005 (-0.21%)
At close: Dec 5, 2025
Antibiotice Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 648.05 | 686.13 | 614.16 | 497.5 | 376.76 | 346.78 | Upgrade
|
| Other Revenue | 0.91 | 2.57 | 1.12 | 7.5 | 2.07 | 0.45 | Upgrade
|
| Revenue | 648.96 | 688.7 | 615.29 | 505 | 378.83 | 347.22 | Upgrade
|
| Revenue Growth (YoY) | -1.36% | 11.93% | 21.84% | 33.31% | 9.10% | -12.13% | Upgrade
|
| Cost of Revenue | 245.62 | 254.42 | 232.64 | 187.45 | 146.97 | 109.56 | Upgrade
|
| Gross Profit | 403.34 | 434.28 | 382.65 | 317.55 | 231.86 | 237.66 | Upgrade
|
| Selling, General & Admin | 182.46 | 171.14 | 161.69 | 130.53 | 125.92 | 118.01 | Upgrade
|
| Other Operating Expenses | 97.71 | 110.9 | 95.66 | 91.94 | 47.57 | 60.43 | Upgrade
|
| Operating Expenses | 331.55 | 327.09 | 285.23 | 244.73 | 197.61 | 200.24 | Upgrade
|
| Operating Income | 71.79 | 107.19 | 97.42 | 72.81 | 34.25 | 37.42 | Upgrade
|
| Interest Expense | -4.51 | -4.54 | -4.15 | -3.59 | -3.52 | -4.93 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.74 | 0.26 | -0.95 | -0.8 | -0.22 | -3.72 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.2 | 0.04 | 0.08 | -0.18 | -0.21 | -0.44 | Upgrade
|
| EBT Excluding Unusual Items | 62.74 | 102.95 | 92.42 | 68.25 | 30.3 | 28.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.16 | 0 | 0.1 | - | - | Upgrade
|
| Asset Writedown | - | - | -0.9 | -3.04 | - | - | Upgrade
|
| Pretax Income | 62.74 | 103.11 | 91.52 | 65.31 | 30.3 | 28.33 | Upgrade
|
| Income Tax Expense | 5.84 | 0.91 | 10.44 | 13.84 | 0.36 | 1.94 | Upgrade
|
| Net Income | 56.9 | 102.2 | 81.09 | 51.47 | 29.94 | 26.39 | Upgrade
|
| Net Income to Common | 56.9 | 102.2 | 81.09 | 51.47 | 29.94 | 26.39 | Upgrade
|
| Net Income Growth | -38.34% | 26.04% | 57.54% | 71.92% | 13.46% | -14.39% | Upgrade
|
| Shares Outstanding (Basic) | 671 | 671 | 671 | 671 | 671 | 671 | Upgrade
|
| Shares Outstanding (Diluted) | 671 | 671 | 671 | 671 | 671 | 671 | Upgrade
|
| EPS (Basic) | 0.08 | 0.15 | 0.12 | 0.08 | 0.04 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.08 | 0.15 | 0.12 | 0.08 | 0.04 | 0.04 | Upgrade
|
| EPS Growth | -38.36% | 26.04% | 57.54% | 71.92% | 13.46% | -14.39% | Upgrade
|
| Free Cash Flow | -88.7 | -3.63 | 39.43 | 78.09 | 15.39 | 46.06 | Upgrade
|
| Free Cash Flow Per Share | -0.13 | -0.01 | 0.06 | 0.12 | 0.02 | 0.07 | Upgrade
|
| Dividend Per Share | 0.021 | 0.021 | 0.083 | 0.008 | 0.003 | 0.003 | Upgrade
|
| Dividend Growth | -75.21% | -75.21% | 946.74% | 147.72% | -3.27% | -88.94% | Upgrade
|
| Gross Margin | 62.15% | 63.06% | 62.19% | 62.88% | 61.20% | 68.45% | Upgrade
|
| Operating Margin | 11.06% | 15.56% | 15.83% | 14.42% | 9.04% | 10.78% | Upgrade
|
| Profit Margin | 8.77% | 14.84% | 13.18% | 10.19% | 7.90% | 7.60% | Upgrade
|
| Free Cash Flow Margin | -13.67% | -0.53% | 6.41% | 15.46% | 4.06% | 13.27% | Upgrade
|
| EBITDA | 138.26 | 152.24 | 125.35 | 95.38 | 58.68 | 59.52 | Upgrade
|
| EBITDA Margin | 21.30% | 22.11% | 20.37% | 18.89% | 15.49% | 17.14% | Upgrade
|
| D&A For EBITDA | 66.47 | 45.06 | 27.93 | 22.57 | 24.43 | 22.1 | Upgrade
|
| EBIT | 71.79 | 107.19 | 97.42 | 72.81 | 34.25 | 37.42 | Upgrade
|
| EBIT Margin | 11.06% | 15.56% | 15.83% | 14.42% | 9.04% | 10.78% | Upgrade
|
| Effective Tax Rate | 9.31% | 0.88% | 11.40% | 21.19% | 1.20% | 6.85% | Upgrade
|
| Advertising Expenses | - | - | - | - | 11.01 | 8.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.